ECSP982443A - COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION - Google Patents

COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Info

Publication number
ECSP982443A
ECSP982443A ECSP982443A ECSP982443A EC SP982443 A ECSP982443 A EC SP982443A EC SP982443 A ECSP982443 A EC SP982443A EC SP982443 A ECSP982443 A EC SP982443A
Authority
EC
Ecuador
Prior art keywords
compositions
methods
prostaglandin
intraocular pressure
reduce eye
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Shau-Fong Yen
Warren Reed Kenneth
Mary Sou
Regina Flinn Peacock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982443 priority Critical patent/ECSP982443A/en
Publication of ECSP982443A publication Critical patent/ECSP982443A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición oftálmica mejorada, que incluye agentes activos de prostaglandina, la cual es especialmente útil para bajar la presión intraocular asociada con glaucoma. Se logran mejoras en la eficacia de reducción de la presión intraocular, en la eficacia del conservador, y concentraciones de aditivo reducidas, mediante la utilización de las composiciones dadas a conocer, las cuales incluyen un agente activo de prostaglandina (por ejemplo, isopropil-unoprostona, un metabolito de una prostaglandina de la serie F), en conjunto con tensoactivos no iónicos seleccionados, conservadores y agentes de ajuste de tonicidad no iónicos.An improved ophthalmic composition, including prostaglandin active agents, which is especially useful in lowering the intraocular pressure associated with glaucoma. Improvements in intraocular pressure reduction efficacy, preservative efficacy, and reduced additive concentrations are achieved through the use of the disclosed compositions, which include a prostaglandin active agent (eg, isopropyl-unoprostone , a metabolite of a prostaglandin series F), in conjunction with selected nonionic surfactants, preservatives, and nonionic tonicity adjusting agents.

ECSP982443 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION ECSP982443A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982443 ECSP982443A (en) 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982443 ECSP982443A (en) 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Publications (1)

Publication Number Publication Date
ECSP982443A true ECSP982443A (en) 1999-01-05

Family

ID=42043365

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982443 ECSP982443A (en) 1998-03-12 1998-03-12 COMPOSITIONS AND METHODS TO REDUCE EYE HYPERTENSION

Country Status (1)

Country Link
EC (1) ECSP982443A (en)

Similar Documents

Publication Publication Date Title
MY122237A (en) Compositions and methods for reducing ocular hypertension
AR052252A1 (en) TOPIC FORMULATIONS OF NEPAFENAC
CA2507375A1 (en) Use of rimexolone in the treatment of dry eye
ES2053458T3 (en) USE OF PROSTAGLANDINS A, B AND C AND DERIVATIVES THEREOF, FOR THE TREATMENT OF EYE HYPERTENSION AND GLAUCOMA.
WO2002049615A3 (en) Artificial tear composition containing a combination of three demulcents
RU2004111984A (en) METHOD FOR TREATING MIDDLE EAR INFECTIONS
MX9702349A (en) Use of 9-deoxy prostaglandin derivatives to treat glaucoma.
AR013024A1 (en) DISPOSABLE ABSORBENT ARTICLE THAT HAS A SKIN CARE COMPOSITION CONTAINING AN ENZYME INHIBITOR AND METHOD TO REDUCE ENZYMATIC ACTIVITY.
PE20051052A1 (en) NITROOXY DERIVATIVES OF PROSTAGLANDINS
DE60104872D1 (en) STABILIZED OPHTHALMIC HYDROGEN PEROXIDE SOLUTION
JP5616620B2 (en) Nonionic silicone hydrogel contact lens ophthalmic composition
ES2172485T1 (en) OPHTHALMIC COMPOSITIONS IN THE FORM OF A WATER GEL.
AR009028A1 (en) PHARMACEUTICAL COMPOSITIONS, A PROCEDURE FOR PREPARING SUCH COMPOSITIONS AND USE OF SUCH COMPOSITIONS IN THE TREATMENT OF OPHTHALMIC DISEASES AND METHODS FOR TREATING SUCH DISEASES
KR900002789A (en) Method for preserving ophthalmic solution and composition for same
WO2002049611A3 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
ECSP045387A (en) LIQUID CLEANING COMPOSITION CONTAINING A PRESERVATIVE AND AN EFFECTIVE CHELATING AGENT
ITRM20010438A1 (en) N-ACETYLCISTEIN-BASED OPHTHALMIC PREPARATION FOR THE TREATMENT OF DRY EYE SYNDROME.
US8933006B1 (en) Contact lens cleaning compositions
ES2180299T3 (en) AGENT FOR HAIR MOLDING.
ZA202400215B (en) Aqueous gel composition
ATE462406T1 (en) FOAMABLE COSMETIC CLEANING PREPARATION
BR0209601A (en) Method for the treatment of ocular hypertension and glaucoma
ATE227135T1 (en) OPHTHALMIC COMPOSITIONS CONTAINING MIOTIC ACTIVES AND HYPERTONIC ACTIVES
WO2003011299A3 (en) Treatment of ocular hypertension and glaucoma
AR036276A1 (en) USE OF A 15-CETO-PROSTAGLANDINE COMPOUND FOR THE TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA